Paper17625614
Gene therapy trials for the treatment of high-grade gliomas.
Sonabend AM and 2 others. Gene Ther Mol Biol, 2007. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Gene therapy trials for the treatment of high-grade gliomas. Papers, record 17625614. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17625614
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| K08 NS046430 | NINDS NIH HHS | United States | K08NS046430 | PubMed and NIH |
Source NIH RePORTER
References100
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7213145 | Epidemiologic study of primary intracranial neoplasms. | Arch Neurol | 1981 | https://conductscience.org/library/papers/7213145 | PubMed |
| 2 | 14682372 | Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomas. | J Neurooncol | 2003 | https://conductscience.org/library/papers/14682372 | PubMed |
| 3 | 14520660 | Imaging-guided convection-enhanced delivery and gene therapy of glioblastoma. | Ann Neurol | 2003 | https://conductscience.org/library/papers/14520660 | PubMed |
| 4 | 10350260 | Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens. | J Neurosurg | 1999 | https://conductscience.org/library/papers/10350260 | PubMed |
| 5 | 11960316 | The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study. | Gene Ther | 2002 | https://conductscience.org/library/papers/11960316 | PubMed |
| 6 | 10839262 | Dependence of efficient adenoviral gene delivery in malignant glioma cells on the expression levels of the Coxsackievirus and adenovirus receptor. | J Neurosurg | 2000 | https://conductscience.org/library/papers/10839262 | PubMed |
| 7 | 11304771 | Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas. | J Clin Oncol | 2001 | https://conductscience.org/library/papers/11304771 | PubMed |
| 8 | 7767638 | Retroviruses as vectors. | Br Med Bull | 1995 | https://conductscience.org/library/papers/7767638 | PubMed |
| 9 | 12952282 | Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of recurrent glioblastoma: preliminary observations in a patient with a favorable response to therapy. | J Neurooncol | 2003 | https://conductscience.org/library/papers/12952282 | PubMed |
| 10 | 16257582 | Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme. | Mol Ther | 2006 | https://conductscience.org/library/papers/16257582 | PubMed |
| 11 | 15359291 | Experimental infections of humans with wild-type adenoviruses and with replication-competent adenovirus vectors: replication, safety, and transmission. | Cancer Gene Ther | 2004 | https://conductscience.org/library/papers/15359291 | PubMed |
| 12 | 15449107 | Specific gene suppression using antisense strategy for growth suppression of glioma. | Med Electron Microsc | 2004 | https://conductscience.org/library/papers/15449107 | PubMed |
| 13 | 12839017 | Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results. | J Clin Oncol | 2003 | https://conductscience.org/library/papers/12839017 | PubMed |
| 14 | 8384892 | Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. | Hum Gene Ther | 1993 | https://conductscience.org/library/papers/8384892 | PubMed |
| 15 | 11221866 | Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration. | Cancer Res | 2001 | https://conductscience.org/library/papers/11221866 | PubMed |
| 16 | 15173839 | Targeted therapy for brain tumours. | Nat Rev Drug Discov | 2004 | https://conductscience.org/library/papers/15173839 | PubMed |
| 17 | 8289093 | Loss in expression of the retinoblastoma gene product in human gliomas is associated with advanced disease. | J Neurooncol | 1993 | https://conductscience.org/library/papers/8289093 | PubMed |
| 18 | 12952304 | Neural stem cell biology may be well suited for improving brain tumor therapies. | Cancer J | 2003 | https://conductscience.org/library/papers/12952304 | PubMed |
| 19 | 15509514 | AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study. | Mol Ther | 2004 | https://conductscience.org/library/papers/15509514 | PubMed |
| 20 | 9812900 | Reovirus therapy of tumors with activated Ras pathway. | Science | 1998 | https://conductscience.org/library/papers/9812900 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33776419 | The Current Status of Gene Therapy for the Treatment of Cancer. | Biologics | 2021 | https://conductscience.org/library/papers/33776419 | PubMed |
| 28251571 | Survivin a radiogenetic promoter for glioblastoma viral gene therapy independently from CArG motifs. | Clin Transl Med | 2017 | https://conductscience.org/library/papers/28251571 | PubMed |
| 26598957 | Overview of current immunotherapeutic strategies for glioma. | Immunotherapy | 2015 | https://conductscience.org/library/papers/26598957 | PubMed |
| 26056588 | Gene therapy for malignant glioma. | Mol Cell Ther | 2014 | https://conductscience.org/library/papers/26056588 | PubMed |
| 22049262 | NEURO-ONCOLOGIC PHYSICAL THERAPY FOR THE OLDER PERSON. | Top Geriatr Rehabil | 2011 | https://conductscience.org/library/papers/22049262 | PubMed |
| 20942909 | FasL and FADD delivery by a glioma-specific and cell cycle-dependent HSV-1 amplicon virus enhanced apoptosis in primary human brain tumors. | Mol Cancer | 2010 | https://conductscience.org/library/papers/20942909 | PubMed |
| 19860653 | Stem cells as delivery vehicles for oncolytic adenoviral virotherapy. | Curr Gene Ther | 2009 | https://conductscience.org/library/papers/19860653 | PubMed |
| 18649343 | Evaluation of E1A double mutant oncolytic adenovectors in anti-glioma gene therapy. | J Med Virol | 2008 | https://conductscience.org/library/papers/18649343 | PubMed |
| 18632631 | Low-dose radiation enhances survivin-mediated virotherapy against malignant glioma stem cells. | Cancer Res | 2008 | https://conductscience.org/library/papers/18632631 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17625614
GET https://conductscience.org/api/papers/v1/17625614/references?page=2